Literature DB >> 17110376

CCAAT/enhancer-binding protein (C/EBP) beta is acetylated at multiple lysines: acetylation of C/EBPbeta at lysine 39 modulates its ability to activate transcription.

Teresa I Ceseña1, Jean-Rene Cardinaux, Roland Kwok, Jessica Schwartz.   

Abstract

Transcription factor function can be modulated by post-translational modifications. Because the transcription factor CCAAT/enhancer-binding protein (C/EBP) beta associates with the nuclear coactivator p300, which contains acetyltransferase activity, acetylation of C/EBPbeta was examined to understand its regulation and function. C/EBPbeta is acetylated by acetyltransferases p300 and p300/CREB-binding protein associated factor. Endogenous C/EBPbeta in 3T3-F442A preadipocytes is also recognized by an acetyl-lysine-specific antibody. Analysis of truncations of C/EBPbeta and peptides based on C/EBPbeta sequences identified multiple lysines within C/EBPbeta that can be acetylated. Among these, a novel acetylation site at lysine 39 of C/EBPbeta was identified. Mutation of Lys-39 to arginine or alanine impairs its acetylation and the ability of C/EBPbeta to activate transcription at the promoters for C/EBPalpha and c-fos. Different C/EBPbeta-responsive promoters require different patterns of acetylated lysines in C/EBPbeta for transcription activation. Furthermore, C/EBPbeta acetylation was increased by growth hormone, and mutation of Lys-39 impaired growth hormone-stimulated c-fos promoter activation. These data suggest that acetylation of Lys-39 of C/EBPbeta, alone or in combination with acetylation at other lysines, may play a role in C/EBPbeta-mediated transcriptional activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17110376     DOI: 10.1074/jbc.M511451200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle.

Authors:  Nima Alamdari; Ira J Smith; Zaira Aversa; Per-Olof Hasselgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-10       Impact factor: 3.619

2.  Misexpression of CCAAT/enhancer binding protein beta causes osteopenia.

Authors:  Stefano Zanotti; Lisa Stadmeyer; Anna Smerdel-Ramoya; Deena Durant; Ernesto Canalis
Journal:  J Endocrinol       Date:  2009-02-13       Impact factor: 4.286

3.  Crosstalk between phosphorylation and multi-site arginine/lysine methylation in C/EBPs.

Authors:  Achim Leutz; Ole Pless; Michael Lappe; Gunnar Dittmar; Elisabeth Kowenz-Leutz
Journal:  Transcription       Date:  2011 Jan-Feb

Review 4.  C/EBPß Isoform Specific Gene Regulation: It's a Lot more Complicated than you Think!

Authors:  Aaron J Spike; Jeffrey M Rosen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-02-20       Impact factor: 2.673

5.  Transcriptional regulation of O-GlcNAc homeostasis is disrupted in pancreatic cancer.

Authors:  Kevin Qian; Simeng Wang; Minnie Fu; Jinfeng Zhou; Jay Prakash Singh; Min-Dian Li; Yunfan Yang; Kaisi Zhang; Jing Wu; Yongzhan Nie; Hai-Bin Ruan; Xiaoyong Yang
Journal:  J Biol Chem       Date:  2018-07-23       Impact factor: 5.157

6.  Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits.

Authors:  Ana M M Oliveira; Marcelo A Wood; Conor B McDonough; Ted Abel
Journal:  Learn Mem       Date:  2007-08-29       Impact factor: 2.460

7.  p300 Mediates Muscle Wasting in Lewis Lung Carcinoma.

Authors:  Thomas K Sin; James Z Zhu; Guohua Zhang; Yi-Ping Li
Journal:  Cancer Res       Date:  2019-01-31       Impact factor: 12.701

Review 8.  The importance of being flexible: the case of basic region leucine zipper transcriptional regulators.

Authors:  Maria Miller
Journal:  Curr Protein Pept Sci       Date:  2009-06       Impact factor: 3.272

Review 9.  CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases.

Authors:  Cynthia A Zahnow
Journal:  Expert Rev Mol Med       Date:  2009-04-08       Impact factor: 5.600

10.  C/EBPalpha expression is partially regulated by C/EBPbeta in response to DNA damage and C/EBPalpha-deficient fibroblasts display an impaired G1 checkpoint.

Authors:  R Ranjan; E A Thompson; K Yoon; R C Smart
Journal:  Oncogene       Date:  2009-07-06       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.